Looks at the angiogenic gene therapy in patients with stable angina trial in which genetic substance is infused into the arteries that supply the heart with oxygen. Statement from John Schleicker, participant in a gene trial for angina at Indiana Center for Vascular Biology and Medicine; Impact of the treatment on blood flow and heart function. INSET: Candidates for Angina Trial.